1.
Apolipoprotein E in Alzheimer's disease: an update
by Yu, Jin-Tai
Annual review of neuroscience, 2014, Vol.37 (1), p.79-100

2.
Whole-Exome Sequencing Identifies Rare and Low-Frequency Coding Variants Associated with LDL Cholesterol
by Schmidt, Ellen M
American journal of human genetics, 2014-02-06, Vol.94 (2), p.233-245

3.
Genetic predisposition, modifiable-risk-factor profile and long-term dementia risk in the general population
by Licher, Silvan
Nature medicine, 2019, Vol.25 (9), p.1364-+

4.
APOE associations with severe CAA-associated vasculopathic changes: collaborative meta-analysis
by Rannikmäe, Kristiina
Journal of neurology, neurosurgery and psychiatry, 2014-03, Vol.85 (3), p.300-305

5.
GWAS of Cerebrospinal Fluid Tau Levels Identifies Risk Variants for Alzheimer’s Disease
by Cruchaga, Carlos
Neuron (Cambridge, Mass.), 2013-04-24, Vol.78 (2), p.256-268

6.
Candidate genes for temporal lobe epilepsy: a replication study
by Salzmann, Annick
Neurological sciences, 2008-12-06, Vol.29 (6), p.397-403

7.
Prevalence of Apolipoprotein E4 Genotype and Homozygotes (APOE e4/4) among Patients Diagnosed with Alzheimer’s Disease: A Systematic Review and Meta-Analysis
by Ward, Alex
Neuroepidemiology, 2012-01, Vol.38 (1), p.1-17

8.
Severe hypoglycaemia, mild cognitive impairment, dementia and brain volumes in older adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) cohort study
by Lee, Alexandra K
Diabetologia, 2018-06-30, Vol.61 (9), p.1956-1965

9.
An Alzheimer's-disease-protective APOE mutation
by Zalocusky, Kelly A
Nature medicine, 2019-11, Vol.25 (11), p.1648-1649

10.
Rosiglitazone Monotherapy in Mild-to-Moderate Alzheimer’s Disease: Results from a Randomized, Double-Blind, Placebo-Controlled Phase III Study
by Gold, Michael
Dementia and geriatric cognitive disorders, 2010-09, Vol.30 (2), p.131-146

11.
Increased Calcification in Osteoprotegerin-Deficient Smooth Muscle Cells: Dependence on Receptor Activator of NF-κB Ligand and Interleukin 6
by Callegari, Andrea
Journal of vascular research, 2014-06, Vol.51 (2), p.118-131

12.
The Association between Apolipoprotein E and Traumatic Brain Injury Severity and Functional Outcome in a Rehabilitation Sample
by Ponsford, Jennie
Journal of neurotrauma, 2011-09-01, Vol.28 (9), p.1683-1692

13.
Polymorphisms in C2, CFB and C3 are associated with progression to advanced age related macular degeneration associated with visual loss
by Francis, P J
Journal of medical genetics, 2009-05, Vol.46 (5), p.300-307

14.
Insulin resistance is associated with poorer verbal fluency performance in women
by Ekblad, Laura L
Diabetologia, 2015-08-15, Vol.58 (11), p.2545-2553

15.
Dysexecutive versus amnesic phenotypes of very mild Alzheimer's disease are associated with distinct clinical, genetic and cortical thinning characteristics
by Dickerson, Bradford C
Journal of neurology, neurosurgery and psychiatry, 2011-01, Vol.82 (1), p.45-51

16.
CSF amyloid-β and tau proteins, and cognitive performance, in early and untreated Parkinson's Disease: the Norwegian ParkWest study
by Alves, Guido
Journal of neurology, neurosurgery and psychiatry, 2010-10, Vol.81 (10), p.1080-1086

17.
ApoE Polymorphisms and the Risk of Different Subtypes of Stroke in the Chinese Population: A Comprehensive Meta-Analysis
by Chen, Chunli
Cerebrovascular diseases (Basel, Switzerland), 2016-03, Vol.41 (3-4), p.119-138

18.
Postural instability/gait disturbance in Parkinson's disease has distinct subtypes: an exploratory analysis
by Factor, Stewart A
Journal of neurology, neurosurgery and psychiatry, 2011-05, Vol.82 (5), p.564-568

19.
Replication of Genetic Association Studies in Aortic Stenosis in Adults
by Gaudreault, Nathalie, BSc
The American journal of cardiology, 2011, Vol.108 (9), p.1305-1310

20.
Association Between Cognitive Function and Plasma Lipids of the Elderly After Controlling for Apolipoprotein E Genotype
by Yasuno, Fumihiko, M.D., Ph.D
The American journal of geriatric psychiatry, 2012, Vol.20 (7), p.574-583
